Ethinyl estradiol/drospirenone/levomefolic acid (trade names Beyaz, Safyral) is an oral contraceptive developed by Bayer. Its contraceptive ingredients are ethinyl estradiol, an estrogen and drospirenone, a synthetic progestogen, making it a combined oral contraceptive (COC). It also contains folate as levomefolic acid calcium salt, to lower the risk of complications such as fetal neural tube defects should the drug fail as contraceptive. The drug was approved by the United States Food and Drug Administration on 24 September 2010.

Property Value
dbo:abstract
  • Ethinyl estradiol/drospirenone/levomefolic acid (trade names Beyaz, Safyral) is an oral contraceptive developed by Bayer. Its contraceptive ingredients are ethinyl estradiol, an estrogen and drospirenone, a synthetic progestogen, making it a combined oral contraceptive (COC). It also contains folate as levomefolic acid calcium salt, to lower the risk of complications such as fetal neural tube defects should the drug fail as contraceptive. The drug was approved by the United States Food and Drug Administration on 24 September 2010. (en)
dbo:wikiPageID
  • 30766508 (xsd:integer)
dbo:wikiPageRevisionID
  • 698224588 (xsd:integer)
dbp:class
dbp:component
  • Ethinyl estradiol
  • Drospirenone
  • Levomefolic acid
dbp:legalStatus
  • Rx-only
dbp:licenceUs
  • Beyaz
dbp:medlineplus
  • a601050
dbp:pregnancyUs
  • X
dbp:routesOfAdministration
dbp:tradename
  • Beyaz, Safyral
dbp:type
  • combo
dbp:verifiedrevid
  • 470456527 (xsd:integer)
dct:subject
rdf:type
rdfs:comment
  • Ethinyl estradiol/drospirenone/levomefolic acid (trade names Beyaz, Safyral) is an oral contraceptive developed by Bayer. Its contraceptive ingredients are ethinyl estradiol, an estrogen and drospirenone, a synthetic progestogen, making it a combined oral contraceptive (COC). It also contains folate as levomefolic acid calcium salt, to lower the risk of complications such as fetal neural tube defects should the drug fail as contraceptive. The drug was approved by the United States Food and Drug Administration on 24 September 2010. (en)
rdfs:label
  • Ethinyl estradiol/drospirenone/levomefolic acid (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of